Patents by Inventor Yanxia BI

Yanxia BI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-OX40 ANTIBODY, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
    Publication number: 20240209104
    Abstract: Provided are an anti-OX40 antibody, and a pharmaceutical composition and application thereof. The anti-OX40 antibody or an antigen-binding fragment and pharmaceutical composition thereof can be used for treating a T cell-related disease.
    Type: Application
    Filed: August 26, 2021
    Publication date: June 27, 2024
    Inventors: See Heng WONG, Jianliang LI, Fubin LI, Wei CAI, Xiaohua YAN, Meng TIAN, Junxia ZHANG, Yanxia BI, Caihong WANG
  • ANTIBODY FC REGION HAVING ENHANCED BINDING AFFINITY TO FCYRIIB
    Publication number: 20230220042
    Abstract: Provided is a modified Fc region. The Fc region has at least one amino acid mutation with respect to a parent Fc region. The modified Fc region has improved affinity to Fc?RIIB with respect to the affinity of the parent Fc region to Fc?RIIB Also provided is an antibody containing the modified Fc region, especially an agonistic antibody. The modified Fc region has significant use for optimizing the agonistic activity of the antibody.
    Type: Application
    Filed: December 3, 2020
    Publication date: July 13, 2023
    Applicant: SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
    Inventors: Fubin LI, Yan ZHANG, Mi ZHANG, Yanxia BI, Shihao TIAN, Huihui ZHANG, Shujun LIU